KRRO

Korro Bio, Inc. (KRRO) ESG Analysis Analysis (2026)

Invetso Score: 7.1/10 — Strong · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 7.4 (Strong)

KRRO’s R&D intensity of 21.6% of revenue indicates a science-led operating model, which is typically more resource-efficient than peers with heavier manufacturing footprints.

The company’s low debt-to-equity ratio of 0.41 and net cash position reduce balance-sheet pressure, supporting longer-horizon environmental investment capacity versus leveraged peers.

High gross margin of 72.8% suggests a less material direct emissions and waste profile than industrial peers, though this is an inference from capital-light economics rather than disclosed environmental data.

No disclosed post-August 2025 environmental incidents or regulatory actions were provided, leaving KRRO’s environmental positioning dependent on operating model signals rather than verified sustainability disclosures.

Social

Score:

KRRO’s elevated R&D spend at 21.6% of revenue supports a highly skilled workforce and knowledge-intensive culture, which is generally stronger than peers reliant on lower-skill labor models.

Stock-based compensation of 3.2% of revenue is meaningful but not excessive, suggesting incentive alignment without the heavier dilution-related social friction seen at some biotech peers.

The capital-light profile implied by high margins and low leverage can reduce workforce disruption risk versus peers facing restructuring or asset-intensive operating complexity.

No material labor, product safety, or community controversy was provided, so the social score reflects structural operating characteristics rather than disclosed stakeholder outcomes.

Governance

Score:

Low leverage and net cash indicate conservative financial governance, which is generally stronger than peers that rely on debt to fund operations.

Stock-based compensation at 3.2% of revenue is manageable, but it still creates dilution and pay-governance scrutiny relative to peers with tighter equity compensation discipline.

The very high R&D ratio implies sustained capital allocation risk, because governance quality depends on disciplined prioritization and milestone execution versus similarly research-intensive peers.

No board composition, audit, or controversy disclosures were provided, limiting confidence that KRRO’s governance is structurally superior to peers beyond balance-sheet conservatism.

Overall Score

Score:

KRRO screens as a strong ESG relative to peers because its capital-light, research-driven model and conservative leverage profile support lower structural ESG risk than many comparables.

Score Driver: Capital-Light Operating Model With Low Leverage

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Korro Bio, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →